Incapacitated Capicua in Sorafenib-Resistant HCC

Cell Mol Gastroenterol Hepatol. 2020;10(2):428-429. doi: 10.1016/j.jcmgh.2020.03.007. Epub 2020 Apr 27.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Carcinoma, Hepatocellular* / drug therapy
  • Drug Resistance, Neoplasm / drug effects
  • Humans
  • Liver Neoplasms* / drug therapy
  • Sorafenib / therapeutic use

Substances

  • Antineoplastic Agents
  • Sorafenib